Share

    


Home / Search Results

Search Results

You searched for:

    Displaying results 1 - 20 of 27
  • 1
  • 2
  • »
ACCC recently announced a collaboration with the Digital Medicine Society on a project to develop a risk prediction tool for cytokine release syndrome.
As immune checkpoint inhibitors have become the standard of care for eligible patients with NSCLC, frequent monitoring of irAEs as well as provider and patient education on the signs and symptoms of pneumonitis can ensure improved clinical outcomes for patients.
The Ohio State University Comprehensive Cancer Center developed the James Cancer Diagnostic Center, to deliver a comprehensive assessment of signs or symptoms of malignancy in a timely fashion.
ACCC Buzz had an opportunity to speak with Jonathan Govette, co-founder and chief operating officer at Oatmeal Health, to learn more about its virtual clinic and patient engagement services and cancer screenings.
With the variety of models and titles that have emerged under precision medicine stewardship, learn how one cancer program is breaking down the this complex landscape into streamlined workflows to improve efficiency and better support growing test volumes.
ACCC conducted a comprehensive survey and a series of four focus groups to explore current attitudes, beliefs, and concerns related to multi-cancer early detection.
Introduced in 2021, the Cancer Patient Equity Act seeks to provide coverage of certain cancer diagnostic and laboratory tests under Medicare, Medicaid, and the Children's Health Insurance Program, and more.
In recognition of the13th annual Metastatic Breast Cancer Awareness Day, read one patient's inspiring journey, a story punctuated by incredible bravery and indomitable hope.
Care optimization is everything in today’s rapidly changing healthcare landscape. Learn how ACCC's nationwide quality improvement (QI) initiative helped Southern Ohio Medical Center Cancer Center develop and implement plans to support the optimization of care for patients diagnosed with Stages III and IV non-small cell lung cancer (NSCLC).
On September 16, the National Comprehensive Cancer Network convened experts and stakeholders in D.C. for a policy summit spotlighting today’s cancer screening and prevention landscape. Learn what speakers discussed, including what changes need to happen to create an equitable future for all people at risk—or not—for cancer.
Cancer and its treatment impact patients in many ways, beginning before a diagnosis and lasting long through survivorship, including one's sexual health. All of Me was created to bridge this communication gap between patients and providers.
To fill a care gap, The James Cancer Hospital opened a new set of front doors to its facility—The James Cancer Diagnostic Center—to ensure all patients with a concern for cancer could be quickly evaluated, even if they didn’t have a confirmed diagnosis.
With an aging U.S. population and a projected shortage of medical oncologists, oncology pharmacists and the critical support they provide in the management of patient symptoms and comorbidities is more important than ever.
The Iowa Oncology Society launched an educational project designed to spark conversations, and raise awareness about the importance of genetic testing, counseling, and screening.
Disparities in evaluation, management, and mortality persist in patient populations where bladder cancer is less common.
The COVID-19 pandemic has had a negative impact in the rate of cancer screening across various states in the United States. Louisiana, Delaware, Kentucky and Northern Michigan serve as vehicles for an analysis of the disparity in cancer screening rates, before and after the pandemic.
The second post in a three-blog series, ACCCBuzz shares how Carolina Blood and Cancer Care Associates' NOLA initiative is addressing access to care, clinical trials, biomarker testing, and more.
March is Multiple Myeloma Awareness Month. Learn how ACCC is supporting collaboration among healthcare providers with practical, scalable solutions to the real-world challenges of improving quality care delivery for patients with multiple myeloma.
In 2021, ACCC held a series of focus groups to learn how cancer programs are effectively implementing telehealth to manage symptoms and treatment side effects, deliver psychosocial screening and support services, and provide genetic counseling and testing.
An expert ACCC Steering Committee shares 32 informed treatment and care delivery recommendations for the ideal care of patients with non-small cell lung cancer.
    Displaying results 1 - 20 of 27
  • 1
  • 2
  • »